Serotherapy in paediatric allogeneic stem cell transplantation: comparison of ATG and Campath-1H as part of conditioning

被引：0
|
作者：
Jol-van der Zijde, C. M. [1 ]
Jansen-Hoogendijk, A. M. [1 ]
Egeler, R. [1 ]
Lankester, A. C. [1 ]
Bredius, R. G. M. [1 ]
van Tol, M. J. D. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, NL, Netherlands
来源：
BONE MARROW TRANSPLANTATION | 2009年 / 43卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S126 / S126
页数：1
相关论文
共 50 条
  • [1] Impact of serotherapy on the outcome after stem cell transplantation in children: ATG versus Campath-1H
    Jol-van der Zijde, C. M.
    Willemsen, L.
    Putter, H.
    Lankester, A. C.
    Bredius, R. G. M.
    van Tol, M. J. D.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S54 - S54
  • [2] Campath-1H allows non-myelosuppressive conditioning for allogeneic stem cell transplantation.
    Claxton, DF
    Kopp, M
    Mierski, J
    Ehmann, WC
    Rybka, W
    BLOOD, 2002, 100 (11) : 430A - 430A
  • [3] A comparison of Campath and Thymoglobulin as part of the conditioning before allogeneic hematopoietic stem cell transplantation
    Norlin, Anna-Carin
    Remberger, Mats
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (01) : 57 - 66
  • [4] Outcome of reduced toxicity allogeneic stem cell transplantation with Campath-1H for myelofibrosis: a single centre experience
    Publicover, A.
    Richardson, D. S.
    Hill, K.
    Hurlock, C.
    Main, S.
    McKeag, N.
    Newman, J.
    Ross, F. M.
    Orchard, K. H.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S236 - S236
  • [5] Alemtuzumab (Campath-1H) in allogeneic stem cell transplantation: Where do we go from here?
    Chakrabarti, S
    Hale, G
    Waldmann, H
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (05) : 1225 - 1227
  • [6] Submyeloablative conditioning regimen using CAMPATH 1-H for allogeneic stem cell transplantation.
    Carrum, G
    Przepiorka, D
    Popat, U
    Heslop, H
    Krance, R
    Kuehnle, I
    May, R
    Bollard, C
    Gottschalk, S
    Brenner, M
    BLOOD, 2002, 100 (11) : 434B - 434B
  • [7] ATG as part of the preparative regimen for paediatric allogeneic peripheral blood stem cell transplantation
    Kupesiz, A
    Tezcan, G
    Hazar, V
    Yesilipek, MA
    BONE MARROW TRANSPLANTATION, 2004, 33 : S225 - S226
  • [8] Influence of post-transplant serum concentration of ATG and Campath-1H on immune recovery in children after stem cell transplantation
    Zijde, E. Jol-van der
    Schenk, C.
    Jansen-Hoogendijk, A.
    Lankester, A.
    Bredius, R.
    Van Tol, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S27 - S28
  • [9] Reducing pretransplant Campath-1H dose does not prevent early CMV reactivation post allogeneic stem cell transplantation
    Schunn, G
    Devetten, MP
    Craig, M
    Bunner, P
    Beall, C
    Ericson, SG
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 59 - 60
  • [10] In vivo CAMPATH-1H prevents GvHD following nonmyeloablative stem-cell transplantation
    Kottaridis, PD
    Milligan, DW
    Chopra, R
    Chakraverty, RK
    Chakrabarti, S
    Robinson, S
    Peggs, K
    Verfuerth, S
    Pettengell, R
    Marsh, JCW
    Schey, S
    Mahendra, P
    Morgan, GJ
    Hale, G
    Waldmann, H
    de Elvira, MCR
    Williams, CD
    Devereux, S
    Linch, DC
    Goldstone, AH
    Mackinnon, S
    CYTOTHERAPY, 2001, 3 (03) : 197 - 201
12345